Medication-related impulse control and repetitive behaviors in Parkinson's disease

Purpose of reviewA range of impulse control and repetitive behaviors presumed to be related to dopaminergic medications has been recognized in Parkinson's disease. These behaviors are linked by their incentive or reward-based and repetitive natures and overlap with addictions. The behaviors include pathological gambling, hypersexuality, compulsive shopping, and compulsive eating and are related to punding and compulsive medication use. In patients on dopamine agonists, these behaviors as a group are relatively common, can have potentially devastating psychosocial consequences and are commonly hidden. Recent findingsRecent studies have investigated prevalence rates and associated factors. The literature on these behaviors in Parkinson's disease, including definitions, epidemiology, pathophysiology and management, is reviewed. The relationship to medications, Parkinson's disease and individual susceptibility is examined. SummaryThese behaviors can affect up to 14% of Parkinson's disease patients on dopamine agonists. Clinicians should warn patients prior to initiating dopamine agonists and enquire about these behaviors during follow up.

[1]  Young T. Hong,et al.  Nucleus Accumbens D2/3 Receptors Predict Trait Impulsivity and Cocaine Reinforcement , 2007, Science.

[2]  A. Lang,et al.  Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. , 2007, Archives of neurology.

[3]  M. Silber,et al.  Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists , 2007, Neurology.

[4]  R. Cools.  Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease , 2006, Neuroscience & Biobehavioral Reviews.

[5]  D. Grosset,et al.  Problematic gambling on dopamine agonists: Not such a rarity , 2006, Movement disorders : official journal of the Movement Disorder Society.

[6]  G. Brighetti,et al.  Prevalence of pathological gambling in patients with Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[7]  R. Katzenschlager,et al.  Punding and dyskinesias , 2006, Movement disorders : official journal of the Movement Disorder Society.

[8]  Y. Agid,et al.  Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation , 2006, Movement disorders : official journal of the Movement Disorder Society.

[9]  E. Foncke,et al.  Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  S. Bassett,et al.  Clinical features associated with impulse control disorders in Parkinson disease , 2006, Neurology.

[11]  A. Lang,et al.  Prevalence of repetitive and reward-seeking behaviors in Parkinson disease , 2006, Neurology.

[12]  Ronald J. Faber,et al.  Estimated prevalence of compulsive buying behavior in the United States. , 2006, The American journal of psychiatry.

[13]  V. Voon,et al.  Dopamine receptor agonists and levodopa and inducing psychosis-like behavior in the MPTP primate model of Parkinson disease. , 2006, Archives of neurology.

[14]  R. Dolan,et al.  Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans , 2006, Nature.

[15]  M. Potenza.  Should addictive disorders include non-substance-related conditions? , 2006, Addiction.

[16]  P. Moberg,et al.  Association of dopamine agonist use with impulse control disorders in Parkinson disease. , 2006, Archives of neurology.

[17]  A. Lang,et al.  Prospective prevalence of pathologic gambling and medication association in Parkinson disease , 2006, Neurology.

[18]  Yen F. Tai,et al.  Compulsive drug use linked to sensitized ventral striatal dopamine transmission , 2006, Annals of neurology.

[19]  C. Waters,et al.  Compulsive eating and weight gain related to dopamine agonist use , 2006, Movement disorders : official journal of the Movement Disorder Society.

[20]  Wim van den Brink,et al.  Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. , 2006, Addiction.

[21]  O. Suchowersky,et al.  Gambling and Parkinson disease. , 2006, Archives of neurology.

[22]  A. Lawrence,et al.  Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease , 2005, Neurology.

[23]  Y. Geda,et al.  Pathological gambling caused by drugs used to treat Parkinson disease. , 2005, Archives of neurology.

[24]  S. Hyman.  Addiction: a disease of learning and memory. , 2005, The American journal of psychiatry.

[25]  A J Lees,et al.  Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[26]  Trevor W Robbins,et al.  Interactions between Serotonin and Dopamine in the Control of Impulsive Choice in Rats: Therapeutic Implications for Impulse Control Disorders , 2005, Neuropsychopharmacology.

[27]  J. Gläscher,et al.  Pathological gambling is linked to reduced activation of the mesolimbic reward system , 2005, Nature Neuroscience.

[28]  C. Colosimo,et al.  Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[29]  Michael J. Frank,et al.  By Carrot or by Stick: Cognitive Reinforcement Learning in Parkinsonism , 2004, Science.

[30]  A. Hofman,et al.  Smoking and Parkinson's disease: Systematic review of prospective studies , 2004, Movement disorders : official journal of the Movement Disorder Society.

[31]  Regina Katzenschlager,et al.  Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome , 2004, Movement disorders : official journal of the Movement Disorder Society.

[32]  P. Skudlarski,et al.  An Fmri Stroop Task Study of Ventromedial Prefrontal Cortical Function in Pathological Gamblers Image Acquisition , 2022 .

[33]  A. Lawrence,et al.  Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry? , 2003, The Lancet Neurology.

[34]  F. Karayanidis,et al.  Disrupted sensory gating in pathological gambling , 2003, Biological Psychiatry.

[35]  Thomas Boraud,et al.  Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function , 2003, Nature Medicine.

[36]  Nicholas W Wood,et al.  Parkin disease: a phenotypic study of a large case series. , 2003, Brain : a journal of neurology.

[37]  W. Schultz,et al.  Discrete Coding of Reward Probability and Uncertainty by Dopamine Neurons , 2003, Science.

[38]  M. Millan,et al.  Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes , 2002, Journal of Pharmacology and Experimental Therapeutics.

[39]  T. Robbins,et al.  Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. , 2002, Brain : a journal of neurology.

[40]  Peter Olausson,et al.  Impairments of Reversal Learning and Response Perseveration after Repeated, Intermittent Cocaine Administrations to Monkeys , 2002, Neuropsychopharmacology.

[41]  T. Goldberg,et al.  Dopaminergic modulation of cortical function in patients with Parkinson's disease , 2002, Annals of neurology.

[42]  J S Fowler,et al.  Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. , 2001, The American journal of psychiatry.

[43]  T. Robbins,et al.  Mechanisms of cognitive set flexibility in Parkinson's disease. , 2001, Brain : a journal of neurology.

[44]  W R True,et al.  Common genetic vulnerability for pathological gambling and alcohol dependence in men. , 2000, Archives of general psychiatry.

[45]  A. Lees,et al.  Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies , 2000, Journal of neurology, neurosurgery, and psychiatry.

[46]  H. de Wit,et al.  Effects of methamphetamine on the adjusting amount procedure, a model of impulsive behavior in rats , 1999, Psychopharmacology.

[47]  J. Vander Bilt,et al.  Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. , 1999, American journal of public health.

[48]  J. Friedman,et al.  Punding on L‐dopa , 1999, Movement disorders : official journal of the Movement Disorder Society.

[49]  J. Hollerman,et al.  Dopamine neurons report an error in the temporal prediction of reward during learning , 1998, Nature Neuroscience.

[50]  P. Södersten,et al.  Altered dopamine function in pathological gambling , 1997, Psychological Medicine.

[51]  P Duffy,et al.  Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[52]  Y. Agid,et al.  Continuous and intermittent levodopa differentially affect basal ganglia function , 1989, Annals of neurology.

[53]  T. Robbins,et al.  L-DOPA Disrupts Activity in the Nucleus Accumbens during Reversal Learning in Parkinson's Disease , 2007, Neuropsychopharmacology.

[54]  A. Verma.  Prevalence of repetitive and rewardseeking behaviors in Parkinson disease , 2007 .